| 标题 |
Bimekizumab durability of efficacy through 196 weeks and safety through 4 years in patients with moderate to severe plaque psoriasis: Results from the BE BRIGHT open-label extension trial |
| 网址 | |
| DOI | |
| 其它 |
期刊:Journal of The American Academy of Dermatology 作者:Andrew Blauvelt; Richard G. Langley; Mark Lebwohl; Bruce Strober; Richard B. Warren; et al 出版日期:2025-04-24 |
| 求助人 | |
| 下载 | 该求助完结已超 24 小时,文件已从服务器自动删除,无法下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)